|11-22-2017 02:06 PM CET - Health & Medicine||
3 Big Competitors (Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies) is Followed "Genotyping Market" With Highest CAGR of +24.22% by 2024
Press release from: Data Bridge Market Research
The new report titled “Global Genotyping Market 2017-2024” By Product & Services (Instruments, Reagents & Kits, Bioinformatics Software, Genotyping Services), By Technology (Microarray, Capillary Electrophoresis, Sequencing, PCR, Maldi-Tof), By Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology), By End User, By Geography – Industry Trends and Forecast to 2024
The Global Genotyping Market accounted to USD 7.58 billion in 2016 growing at a CAGR of 24.22% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
This report consists of below pages:
• No of pages: 350
• No of Figures: 60
• No of Tables: 220
Get Free Sample Copy of this Report @ databridgemarketresearch.com/request-a-sample/?dbmr=globa...
Genotyping is a technique of defining genetic make-up differences of an individual by examining the individual’s DNA sequence by means of the biological assays and for comparing it to other individual’s sequence. Genotyping enables researchers to explore genetic variants such as single nucleotide polymorphisms (SNPs) and large structural changes in DNA.
Major Market Drivers and Restraints:
• Rising prevalence of genetic diseases, such as Alzheimer’s, Parkinson’s, hemophilia, thalassemia and turner syndrome
• Early diagnosis and rapid sequencing helps professionals for the treatment
• Technological developments in DNA sequencing
• Deteriorating prices of DNA sequencing
• Rising significance of SNP genotyping
• Increasing demand for genome analysis in animal and plant livestock
• Unfavorable reimbursement policies
The global genotyping market is segmented by product and services into instruments, reagents & kits, bioinformatics software and genotyping services, Instruments are further sub segmented into sequencers & amplifiers and analyzers.
On the basis of technology the market is segmented into microarray, capillary electrophoresis, sequencing, PCR and Maldi-tof.
On the basis of application the market is segmented into pharmacogenomics, diagnostic research, animal genetics and agricultural biotechnology.
By end user the market is segmented into pharmaceutical and biopharmaceutical companies, diagnostic & research laboratories and academic institutions.
On the basis of geography, genotyping market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.
Read more about the Global Genotyping Market Report Visit @ databridgemarketresearch.com/reports/global-genotyping-ma...
The genotyping market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of genotyping market for global, Europe, North America, Asia Pacific and South America.
Major Market Competitors:
Some of the major players operating in genotyping market report are Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Bioline, Qiagen, Danaher, F. Hoffmann-La Roche Ltd., General Electric Company, Sequenom, FLUIDIGM, BiogeniQ Inc., Envigo, Helix, LGC Limited, Genotypic Technology Pvt Ltd, Eurofins Genomics, Biofortuna Ltd, Agena Bioscience, Inc., BioTechniques, Precision Biomarker Resources, Inc., TrimGen Corporation, 23andMe, Inc., Xcelris Genomics, Integrated DNA Technologies, Inc. and BioTek Instruments, Inc. among others.
Order a copy of Tissue Regeneration Market Report @ databridgemarketresearch.com/inquire-before-buying/?dbmr=...
Global Transfection Reagents and Equipment Market – Industry Trends and Forecast to 2024
Global Transfection Reagents and Equipment Market By Product Type (Reagents, Equipments), By Method (Biochemical (Lipofection, Calcium Phosphate, Deae-dextran, Dendrimers), Physical (Electroporation, Nucleofection, Sonoporation, Genegun, Magnetofection, Optoinjection), Viral (Adenoviruses, Retroviruses, Adenoassociated viruses)), By Application (Biomedical Research (Gene Expression Studies, Cancer Research, Transgenic Models), Protein Production, Therapeutic Deliver), By End User (Pharmaceutical & Biotechnology Companies, Academics, Research Laboratories) By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024
Report Access: databridgemarketresearch.com/reports/global-transfection-...
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
Visit Blog: databridgemarketresearch.com/blog/
Follow us on LinkedIn: www.linkedin.com/company/data-bridge-market-research
This release was published on openPR.
News-ID: 828906 • Views: 268More releases